Discovery channel feed – Endpoints News

Discovery channel feed

Reckoning the potential of CRISPR/Cas9 tech, NIH launches $190M genome editing research initiative

8 years ago

Preclinical study finds Genmab may hold the key to a next-gen triple followup to MEK/BRAF combos

8 years ago

Stanford trial points to a new CAR-T drug, spotlighting a fresh target for next-gen cell therapies

8 years ago

Novartis and Amgen launch new Alzheimer's study

8 years ago

California upstart Xyphos wants to tackle CAR-T's big problems

8 years ago

Expanding its preclinical attack on Duchenne MD, Sarepta grabs a license for Duke's CRISPR tech

8 years ago

Takeda is beefing up its NASH pipeline with a $470M discovery deal with HemoShear

8 years ago

AstraZeneca and Moderna take a big, early step forward in their quest to prove mRNA works in humans

8 years ago

CSL snags a preclinical stem cell therapy in $416M Calimmune buyout, plans to spin out HIV effort

8 years ago

AI drug discovery success inspires a machine-learning startup at the Mayo Clinic

8 years ago

CRISPR crew’s lab test spotlights lead program in sickle cell disease, beta-thalassemia

8 years ago

Researchers develop a small-molecule 'sunless tan' to guard against skin cancer

8 years ago

Harvard researchers hope to bridge the protein gap with new institute

8 years ago

Ben-Gurion University seeking partner to repurpose old lymphoma drug to treat ALS

8 years ago

Serial startup scientist Ronald Evans tests a new Mighty Mouse drug, making marathon runners with a pill

9 years ago

Little Abivax sees volatile shares rocket up on a (very early-stage) report of an HIV breakthrough

9 years ago

Tired of being dumped by pharma partners, Vanderbilt’s neuroscience team takes a bold aim at the clinic

9 years ago

Google Ventures’ Krishna Yeshwant is hunting for the next big new idea in biotech

9 years ago

Are 'great' tweeters born? Or can they be made? A conversation with Adam Feuerstein.

9 years ago

First page Previous page 8 9 1011